Related Experiment Videos

Diagnosis and management of children with Kawasaki disease

S S Gidding1, S T Shulman

  • 1Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois.

Heart Disease and Stroke : a Journal for Primary Care Physicians
|July 1, 1994
PubMed

Insights

Kawasaki disease management has improved significantly, with intravenous gamma globulin therapy reducing mortality. Future research aims to uncover the cause and develop better diagnostics and treatments for this childhood illness.

Area of Science:

  • Pediatrics
  • Immunology
  • Cardiology

Background:

  • Kawasaki disease is a critical childhood illness with significant cardiovascular implications.
  • Understanding its epidemiology and natural history has advanced since 1967.
  • Coronary artery abnormalities remain a primary concern.

Purpose of the Study:

  • To review the progress in Kawasaki disease management.
  • To highlight advancements in treatment and their impact on mortality.
  • To outline future research priorities for etiology, pathogenesis, and therapy.

Main Methods:

  • Literature review of epidemiological and clinical studies.
  • Analysis of treatment outcomes, focusing on intravenous gamma globulin.
  • Synthesis of current understanding and identification of research gaps.

Main Results:

  • Mortality rates for Kawasaki disease have decreased to below 1%.
  • Intravenous gamma globulin therapy and vigilant care are key factors in improved outcomes.
  • Significant progress in understanding the disease's epidemiology and natural history.

Conclusions:

  • Modern management strategies have drastically improved Kawasaki disease survival rates.
  • Further research is crucial to identify the disease's cause and refine diagnostic and therapeutic approaches.
  • Preventing long-term coronary artery disease complications remains a key objective.

Related Concept Videos